148 related articles for article (PubMed ID: 4303694)
1. [The role of foot-and-mouth disease antibodies of sera in BHK 21 industrial cell cultures used for the production of vaccines].
Mammerickx M; Leunen J
Bull Off Int Epizoot; 1968; 69(3):487-96. PubMed ID: 4303694
[No Abstract] [Full Text] [Related]
2. [Safety of foot-and-mouth disease vaccines in cell cultures].
Tekerlekov P; Dilovski M; Gergov P; Nikolova E
Vet Med Nauki; 1982; 19(1):21-5. PubMed ID: 6287707
[TBL] [Abstract][Full Text] [Related]
3. [Cultivation of foot-and-mouth disease virus type O in tissue cultures and utilization of its mutability for the production of new vaccine strains].
Mitev G; Tekerlekov P
Arch Exp Veterinarmed; 1966 Mar; 20(1):91-7. PubMed ID: 4293437
[No Abstract] [Full Text] [Related]
4. Foot-and-mouth disease vaccine: influence of the vaccine virus subtype on neutralizing antibody and resistance to disease.
Graves JH; McKercher PD; Callis JJ
Am J Vet Res; 1972 Apr; 33(4):765-8. PubMed ID: 4336082
[No Abstract] [Full Text] [Related]
5. [Studies on the suitability of tissue culture neutralization tests in the government etesting of adsorbed foot-and mouth disease vaccines. 1. The content of neutralizing antibody in the serum of cattle after vaccination with adsorbed vaccine against type O2 virus in comparison with the direct immunity testing in cattle].
Rüting E; Seils H; Weyhe D; Benndorf E
Arch Exp Veterinarmed; 1969; 23(4):827-38. PubMed ID: 4319494
[No Abstract] [Full Text] [Related]
6. The suitability of a rolled BHK21 monolayer system for the production of vaccines against the SAT types of foot-and-mouth disease virus. I. Adaptation of virus isolates to the system, immunogen yields achieved and assessment of subtype cross reactivity.
Esterhuysen JJ; Thomson GR; Ashford WA; Lentz DW; Gainaru MD; Sayer AJ; Meredith CD; Janse van Rensburg D; Pini A
Onderstepoort J Vet Res; 1988 Jun; 55(2):77-84. PubMed ID: 2839810
[TBL] [Abstract][Full Text] [Related]
7. Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines.
Terpstra C; Frenkel S; Straver PJ; Barteling SJ; van Bekkum JG
Dev Biol Stand; 1976; 35():333-42. PubMed ID: 198304
[No Abstract] [Full Text] [Related]
8. [Immunogenic properties of foot-and-mouth vaccines].
Tekerlekov P; Nikolova E; Dilovski M
Vet Med Nauki; 1983; 20(5-6):46-51. PubMed ID: 6318424
[TBL] [Abstract][Full Text] [Related]
9. [Immunobiological properties of strains of foot-and-mouth disease virus multiplying in cell cultures].
Efimov NI; Siusiukin AA; Shvetsova RV; Serodzhev AT
Veterinariia; 1975 May; (5):53-5. PubMed ID: 174272
[No Abstract] [Full Text] [Related]
10. Large-scale cultivation of animal cells in roller bottles for production of decigram amounts of pure foot-and-mouth disease virus.
Bachrach HL
Natl Cancer Inst Monogr; 1968 Dec; 29():73-9. PubMed ID: 4305442
[No Abstract] [Full Text] [Related]
11. [Studies of sero-neutralization in mice used for measurement of post-vaccination immunity of cattle to foot-and-mouth disease].
Maupas P; Perraud J
Bull Off Int Epizoot; 1969; 71(3-4):509-17. PubMed ID: 4323533
[No Abstract] [Full Text] [Related]
12. Foot and mouth disease virus production on microcarrier-grown cells.
Meignier B; Mougeot H; Favre H
Dev Biol Stand; 1980; 46():249-56. PubMed ID: 6245001
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the immunologic properties of foot-and-mouth disease vaccines].
Tekerlekov P; Gergov P; Nikolova E
Vet Med Nauki; 1982; 19(3):29-34. PubMed ID: 6291225
[No Abstract] [Full Text] [Related]
14. Antibody response of tropical range cattle to foot-and-mouth disease virus. II. Evaluation of response to O-1, A-27, and A-18 subtypes.
Arias CA; Hanson RP; de Gerardino AG
Dev Biol Stand; 1976; 35():215-20. PubMed ID: 198289
[No Abstract] [Full Text] [Related]
15. [Possibilities and limits of immunochemical methods (radio- and enzyme immunoassay) in testing foot-and-mouth disease vaccine].
Schilow WF; Reimann I
Arch Exp Veterinarmed; 1984 Sep; 38(5):697-703. PubMed ID: 6099107
[No Abstract] [Full Text] [Related]
16. Residual foot-and-mouth disease virus antibodies in French cattle and sheep six years after the vaccination ban.
Remond M; Kaiser C; Lebreton FO; Moutou F; Crucière C
Vet Res; 2001; 32(1):81-6. PubMed ID: 11254180
[TBL] [Abstract][Full Text] [Related]
17. [Comparatve serological and immunological study of strains of foot-and-mouth disease virus type "O" isolated in Europe between 1963 and 1966].
Moosbrugger GA; Leunen J; Mackowiak C; Fontaine J; Roumiantzeff M
Bull Off Int Epizoot; 1967; 67(5):711-29. PubMed ID: 4303616
[No Abstract] [Full Text] [Related]
18. [The efficacy of foot and mouth disease vaccines after long- term storage].
Wittmann G
Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):33-4. PubMed ID: 6248022
[No Abstract] [Full Text] [Related]
19. [Changes in antigen properties of foot-and-mouth disease virus during several passages].
Salajov EL; Avilov VS; Revenkov AG
Bull Off Int Epizoot; 1972; 77(5):935-40. PubMed ID: 4350009
[No Abstract] [Full Text] [Related]
20. Comparison of a bovine enterovirus and foot-and-mouth disease virus.
Scott FW; Cottral GE
Am J Vet Res; 1967 Sep; 28(126):1597-600. PubMed ID: 4293282
[No Abstract] [Full Text] [Related]
[Next] [New Search]
